Greenwood Capital Associates’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-27,781
Closed -$2.62M 208
2019
Q1
$2.62M Sell
27,781
-91,211
-77% -$7.98M 0.67% 50
2018
Q4
$7.63M Sell
118,992
-19,278
-14% -$1.42M 2% 12
2018
Q3
$12.4M Sell
138,270
-3,765
-3% -$333K 2.7% 2
2018
Q2
$11.3M Buy
142,035
+111,666
+368% +$9.27M 2.6% 1
2018
Q1
$2.71M Buy
30,369
+7,553
+33% +$725K 0.66% 65
2017
Q4
$2.38M Buy
22,816
+4,045
+22% +$456K 0.55% 76
2017
Q3
$2.74M Buy
18,771
+7,750
+70% +$1.06M 0.68% 68
2017
Q2
$1.43M Buy
11,021
+1,029
+10% +$126K 0.37% 83
2017
Q1
$1.24M Sell
9,992
-153
-2% -$18.3K 0.33% 89
2016
Q4
$1.17M Buy
10,145
+190
+2% +$21.2K 0.33% 85
2016
Q3
$1.04M Buy
9,955
+61
+0.6% +$6.6K 0.32% 83
2016
Q2
$976K Buy
9,894
+24
+0.2% +$2.48K 0.3% 83
2016
Q1
$988K Sell
9,870
-342
-3% -$35.2K 0.31% 82
2015
Q4
$1.22M Buy
10,212
+505
+5% +$58.4K 0.4% 78
2015
Q3
$1.05M Sell
9,707
-28,104
-74% -$3.49M 0.37% 74
2015
Q2
$4.38M Sell
37,811
-847
-2% -$96.8K 1.32% 27
2015
Q1
$4.46M Sell
38,658
-810
-2% -$96.8K 1.28% 29
2014
Q4
$4.42M Buy
39,468
+14,231
+56% +$1.5M 1.28% 27
2014
Q3
$2.39M Buy
+25,237
New +$2.28M 0.73% 64
2014
Q1
Sell
-43,062
Closed -$3.64M 154
2013
Q4
$3.64M Buy
43,062
+130
+0.3% +$10.3K 1.13% 39
2013
Q3
$3.31M Sell
42,932
-1,114
-3% -$78.1K 1.17% 37
2013
Q2
$2.58M Buy
+44,046
New +$2.65M 1.12% 36

Other funds holding CELG

Greenwood Capital Associates's CELG Position: Q2 2019 in Review

Greenwood Capital Associates sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 27,781 shares — an estimated $2.62M sold.

Greenwood Capital Associates first reported a position in CELG in Q2 2013 and held it in 22 quarters. The position peaked at $12.4M in Q3 2018. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Greenwood Capital Associates reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Greenwood Capital Associates sold 27,781 Celgene Corp shares in Q2 2019, an estimated $2.62M.
  • Greenwood Capital Associates first reported a position in Celgene Corp in Q2 2013 and held it in 22 quarters.
  • Greenwood Capital Associates's Celgene Corp position peaked at $12.4M in Q3 2018.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Greenwood Capital Associates's 13F filing for Q2 2019, filed 13 Aug 2019.